Samsung Bioepis Co., Ltd. announced its expansion in mainland China through a licensing agreement with C-Bridge Capital.

Pathios Therapeutics, an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and immuno-oncology and
Sygnature Discovery have announced a strategic partnership to accelerate Pathios’ drug discovery and development programmes.

Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for rare and orphan diseases along with oncology, infectious diseases, and vaccines, is now enrolling patients in the U.S. and Europe into a pivotal Phase III study within the treatment of short bowel syndrome (SBS).

CStone Pharmaceuticals announced that the National Medical Products Administration (NMPA) recently approved the clinical trial application (CTA) to start a Phase I clinical trial in China for BLU-554 (CS3008).

Bavarian Nordic A/S announced , that the first stage of a Phase 2 study of its novel, targeted cancer immunotherapy candidate, BN-Brachyury in the treatment of advanced chordoma has completed recruitment of the planned 10 patients ahead of schedule.

AbbVie , a research-based global biopharmaceutical company, announced the decision to stop enrollment for the TAHOE trial, a Phase 3 study evaluating Rovalpituzumab Tesirine (Rova-T) as a second-line therapy for advanced small-cell lung cancer (SCLC).

WuXi Biologics , a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Amicus Therapeutics .

LabConnect, a leading global provider of central laboratory and support services for biopharmaceutical, medical device, and contract research organizations, is pleased to announce a new service: LabConnect’s global sample processing network (GSPN).

Sharp - a part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has completed its relocation to its $23m state-of-the-art facility in Bethlehem, PA.

Ompi, the Italian glass primary packaging specialist for the pharmaceutical industry, has signed a collaboration agreement with SiO2 Medical Products (SMP).

Aptar Pharma, a leading provider of innovative drug delivery systems, has announced that their recently-launched QuickStart for Injectables has won Best Innovation in Packaging Material & Component category at the 2019 Pharmapack Awards in Paris, France.

Clariant, a world leader in specialty chemicals, and its Healthcare Packaging business line, are exhibiting at Pharmapack 2019 and featuring products that protect the quality and appearance of bulk pharmaceuticals (powders, tablets, capsules, etc.), as well as active ingredients (API) during processing and shipment.